Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PHENAPHEN W/ CODEINE NO. 4

ACETAMINOPHEN; CODEINE PHOSPHATE

Standard Dose
325MG;60MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PHENAPHEN W/ CODEINE NO. 4 is listed in Drugs@FDA under application 084446 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength CAPSULE;ORAL - 325MG;60MG Sponsor ROBINS AH Submission history Latest submission status date: 1998-04-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview PHENAPHEN W/ CODEINE NO. 4 is listed in Drugs@FDA under application 084446 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength CAPSULE;ORAL - 325MG;60MG Sponsor ROBINS AH Submission history Latest submission status date: 1998-04-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
PHENAPHEN W/ CODEINE NO. 4 (ACETAMINOPHEN; CODEINE PHOSPHATE) | Drug Monograph | MedicHelpline